➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Moodys
McKinsey
AstraZeneca
Boehringer Ingelheim

Last Updated: June 1, 2020

DrugPatentWatch Database Preview

Patent: 9,700,597

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,700,597
Title:Methods of treating cognitive impairment
Abstract: The subject invention concerns materials and methods for treating a person or animal having cognitive impairment. In one embodiment, the method comprises administering an effective amount of one or more inflammatory mediator(s), for example, fms-related tyrosine kinase 3 (Flt3) ligand, interleukin-6 (IL-6), macrophage migration inhibitory factor (MIF), interleukin-1 (IL-1), interleukin-3 (IL-3), erythropoietin (EPO), vascular endothelial growth factor A (VEGF-A), hypoxia-inducible transcription factor (HIF-1alpha), insulin like growth factor-1 (IGF-1), tumor necrosis factor (TNF), granulocyte colony-stimulating factor (G-CSF), granulocyte/macrophage colony-stimulating factor (GM-CSF), macrophage colony-stimulating factor (M-CSF), Stem Cell Factor (SCF), Darbepoetin (ARANESP), and metalloproteinases, to an animal or person in need of treatment.
Inventor(s): Potter; Huntington (Denver, CO), Boyd; Timothy (Aurora, CO), Jim; Heather Sevey Lawrence (Tampa, FL)
Assignee: UNIVERSITY OF SOUTH FLORIDA (Tampa, FL) H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (Tampa, FL)
Application Number:14/730,485
Patent Claims:see list of patent claims

Details for Patent 9,700,597

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20   Start Trial UNIVERSITY OF SOUTH FLORIDA (Tampa, FL) H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (Tampa, FL) 2028-08-05 RX search
Amgen NEUPOGEN filgrastim VIAL 103353 002 1991-02-20   Start Trial UNIVERSITY OF SOUTH FLORIDA (Tampa, FL) H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (Tampa, FL) 2028-08-05 RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 003 1991-02-20   Start Trial UNIVERSITY OF SOUTH FLORIDA (Tampa, FL) H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (Tampa, FL) 2028-08-05 RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20   Start Trial UNIVERSITY OF SOUTH FLORIDA (Tampa, FL) H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (Tampa, FL) 2028-08-05 RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 001 1991-03-05   Start Trial UNIVERSITY OF SOUTH FLORIDA (Tampa, FL) H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (Tampa, FL) 2028-08-05 RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 002 1991-03-05   Start Trial UNIVERSITY OF SOUTH FLORIDA (Tampa, FL) H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (Tampa, FL) 2028-08-05 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
McKinsey
Merck
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.